ⓔノート7-5-9　早期治療の重要性

　治療が遅れた群では12週の時点での死亡率が明らかに高い (82.9％ vs 48.6％)¹⁾．

〔掛屋　弘〕

■文献

1. Chamilos G, Lewis RE, et al: Delaying amphotericin B–based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis, 2008; 47: 503–509.